Kelsey Flint1, Erin L Chaussee2, Kamal Henderson3, Khadijah Breathett4, Prateeti Khazanie5, Jocelyn S Thompson2, Colleen K Mcilvennan5, Shane J Larue6, Daniel D Matlock7, Larry A Allen8. 1. Rocky Mountain Regional VA Medical Center, Aurora, Colorado; Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address: Kelsey.flint@cuanschutz.eduw. 2. Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3. Rocky Mountain Regional VA Medical Center, Aurora, Colorado; Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 4. Division of Cardiology, Department of Medicine, Sarver Heart Center, University of Arizona, Tucson, Arizona. 5. Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 6. Hannibal Clinic, Hannibal, Missouri. 7. Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Division of Geriatric Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado; VA Eastern Colorado Geriatric Research Education and Clinical Center, Denver, Colorado. 8. Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Abstract
BACKGROUND: A left ventricular assist device (LVAD) is a treatment option available to select patients with advanced heart failure. However, there are important social determinants of health that can play a role in determining patients' outcomes after device placement. METHODS AND RESULTS: We leveraged the DECIDE-LVAD Trial to assess social determinants of health-relationship status, household income, race/ethnicity, educational attainment, and health insurance-at the time of evaluation, and their association with rate of LVAD placement in the subsequent year. About a quarter of patients were unpartnered (i.e., single/divorced/widowed/separated; n = 55 [26%]). A similar proportion had a household income of less than $20,000 per year (n = 50 [24%]). Few patients were other race (n = 39 [18%]), had less than a high school education (n = 14 [6.6%]), or had Medicaid as their primary payor (n = 17 [8.4%]). LVAD implantation was significantly lower among patients who were unpartnered compared with patients who were married or partnered. LVAD implantation was not associated with income, race, educational attainment or insurance status. CONCLUSIONS: Our data from diverse LVAD centers at U.S. private and academic hospitals found that, among a broad sample of patients being evaluated for LVAD, married or partnered status was favorably associated with LVAD implantation, but other social determinants of health were not. Future research and policy changes should consider novel interventions for improving access to LVAD implantation for patients with inadequate social support.
BACKGROUND: A left ventricular assist device (LVAD) is a treatment option available to select patients with advanced heart failure. However, there are important social determinants of health that can play a role in determining patients' outcomes after device placement. METHODS AND RESULTS: We leveraged the DECIDE-LVAD Trial to assess social determinants of health-relationship status, household income, race/ethnicity, educational attainment, and health insurance-at the time of evaluation, and their association with rate of LVAD placement in the subsequent year. About a quarter of patients were unpartnered (i.e., single/divorced/widowed/separated; n = 55 [26%]). A similar proportion had a household income of less than $20,000 per year (n = 50 [24%]). Few patients were other race (n = 39 [18%]), had less than a high school education (n = 14 [6.6%]), or had Medicaid as their primary payor (n = 17 [8.4%]). LVAD implantation was significantly lower among patients who were unpartnered compared with patients who were married or partnered. LVAD implantation was not associated with income, race, educational attainment or insurance status. CONCLUSIONS: Our data from diverse LVAD centers at U.S. private and academic hospitals found that, among a broad sample of patients being evaluated for LVAD, married or partnered status was favorably associated with LVAD implantation, but other social determinants of health were not. Future research and policy changes should consider novel interventions for improving access to LVAD implantation for patients with inadequate social support.
Authors: Joseph Lockridge; Douglas Norman; Shehzad Rehman; David Scott; Erin Maynard; Debora Bowers; Ingrid Siegman; Kelly Martin Journal: Am J Transplant Date: 2019-08-13 Impact factor: 8.086
Authors: Justin van Meeteren; Simon Maltais; Shannon M Dunlay; Nicholas A Haglund; Mary Beth Davis; Jennifer Cowger; Palak Shah; Keith D Aaronson; Francis D Pagani; John M Stulak Journal: J Heart Lung Transplant Date: 2016-09-07 Impact factor: 10.247
Authors: Robert L Kormos; Jennifer Cowger; Francis D Pagani; Jeffrey J Teuteberg; Daniel J Goldstein; Jeffrey P Jacobs; Robert S Higgins; Lynne W Stevenson; Josef Stehlik; Pavan Atluri; Kathleen L Grady; James K Kirklin Journal: J Heart Lung Transplant Date: 2019-02 Impact factor: 10.247
Authors: Khadijah Breathett; Larry A Allen; Laura Helmkamp; Kathryn Colborn; Stacie L Daugherty; Irene V Blair; Jacqueline Jones; Prateeti Khazanie; Sula Mazimba; Marylyn McEwen; Jeff Stone; Elizabeth Calhoun; Nancy K Sweitzer; Pamela N Peterson Journal: Circ Heart Fail Date: 2018-08 Impact factor: 8.790
Authors: Michael Koeckert; Patrick Vining; Alex Reyentovich; Stuart D Katz; Abe DeAnda; Stefanie Philipson; Leora B Balsam Journal: Heart Lung Date: 2017-01-02 Impact factor: 2.210
Authors: Michael Yaoyao Yin; Jennifer Strege; Edward M Gilbert; Josef Stehlik; Stephen H McKellar; Ashley Elmer; Thomas Anderson; Mossab Aljuaid; Jose Nativi-Nicolau; Antigone G Koliopoulou; Erin Davis; James C Fang; Stavros G Drakos; Craig H Selzman; Omar Wever-Pinzon Journal: JACC Heart Fail Date: 2020-04 Impact factor: 12.035
Authors: Colleen K McIlvennan; Jocelyn S Thompson; Daniel D Matlock; Joseph C Cleveland; Shannon M Dunlay; Shane J LaRue; Eldrin F Lewis; Chetan B Patel; Mary Norine Walsh; Larry A Allen Journal: J Cardiovasc Nurs Date: 2016 Nov/Dec Impact factor: 2.083
Authors: Larry A Allen; Colleen K McIlvennan; Jocelyn S Thompson; Shannon M Dunlay; Shane J LaRue; Eldrin F Lewis; Chetan B Patel; Laura Blue; Diane L Fairclough; Erin C Leister; Russell E Glasgow; Joseph C Cleveland; Clifford Phillips; Vicie Baldridge; Mary Norine Walsh; Daniel D Matlock Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873
Authors: Christopher E Knoepke; Bonnie Siry-Bove; Caitlin Mayton; Abigail Latimer; Jan Hart; Larry A Allen; Stacie L Daugherty; Colleen K McIlvennan; Daniel D Matlock; Prateeti Khazanie Journal: Circ Heart Fail Date: 2022-07-07 Impact factor: 10.447